Capitalize on Matching HL-Antigens  Key to developing clinically relevant immune response

Capitalize on Matching HL-Antigens Key to developing clinically relevant immune response

User Photo
Annual-Meeting

2 years
44 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Chuck Wiseman, MD, BriaCell Therapeutics, discusses Capitalizing on Matching HL-Antigens Key to developing clinically relevant immune response at Annual Meeting 2018
Up Next Autoplay